Title:
Do you suffer from treatment-resistant depression?
|
| What is the purpose of the study? |
| |
The purpose of this research study is to find out if adding an anti-inflammatory medication (minocycline) to standard antidepressant treatment is effective in reducing depressive symptoms in people suffering from treatment-resistant depression.
|
| Who is needed? |
| |
Individuals with: |
Depression |
| |
Individuals without
a mental health or
addiction problem:
|
No
|
| |
Age range: |
18 - 80 |
| |
Gender: |
All |
| |
Ethnicity: |
|
| |
Other:
|
|
| What does the study involve? |
| |
Number of contacts: |
There will be 5 visits with the research team which can be done in-person at CAMH or virtually |
| |
Time period: |
12 weeks |
| |
Length of contacts: |
The first visit will take approximately 3.5 - 4 hours. The other 4 visits will take approx. 1.5 - 2 hours. |
| |
Treatment offered:
|
Yes
|
Location:
|
100 Stokes St. (Queen site)
|
Principal Investigator:
|
Dr. Ishrat Husain
|
| Contact information: |
| |
Phone: |
416-535-8501 ext. 33758 |
| |
e-mail: |
research.study@camh.ca |
| |
Website: |
|
| |
Flyer:
|
Download
|
Study end date:
|
01 Feb 2022
|
| REB number: |
135/2018 |
| Full study title: |
Minocycline as adjunctive treatment for treatment-resistant depression: a double-blind, placebo-controlled, randomized trial (MINDEP2) |
| Keywords: |
Depression, Minocycline, Anti-depressant, Mood, Inflammation |
| Study Area: |
|
